Metabolic and weight-loss effects of a long-term dietary intervention in obese patients

American Journal of Clinical Nutrition

Volumn 69, Issue 2, 1999, Pages 198-204

  Ditschuneit, Herwig H ^a   Flechtner Mors, Marion ^b   Johnson, Timothy D ^b   Adler, Guido ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Biomarkers; Disease risk; Meal replacements; Obesity humans; Weight loss

Indexed keywords

BIOCHEMICAL MARKER; MINERAL; VITAMIN;

ADULT; ARTICLE; CALORIC INTAKE; CALORIC RESTRICTION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLISM; OBESITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

EID: 0032951713     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/69.2.198     Document Type: Article

References (27)

1. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 1995;273:461-5.
2. Lee IM, Paffenbarger RS Jr. Change in body weight and longevity. JAMA 1992;268:2045-9.
3. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
4. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-6.
5. Blackburn GL. Effect of degree of weight loss on health benefits. Obes Res 1995;3(suppl):S211-6.
6. Kanders BS, Blackburn GL. Reducing primary risk factors by therapeutic weight loss. In: Wadden TA, ed. Treatment of the seriously obese patient. New York: Guilford Press, 1992:213-20.
7. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes 1992;16:379-415.
8. Daly PA, Solomon CG, Manson JE. Risk modification in the obese patient. In: Manson JE, Ridker PM, Gaziano JM, Hennekens CH, eds. Prevention of myocardial infarction. New York: Oxford University Press, 1996:203-40.
9. Wadden TA, Sternberg JA, Letizia KA, Stunkard AJ, Foster GD. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: a five-year perspective. Int J Obes 1989; 13(suppl):S39-46.
10. Heber D, Ashley JM, Wang HJ, Elashoff RM. Clinical evaluation of a minimal intervention meal replacement regimen for weight reduction. J Am Coll Nutr 1994;13:608-14.
11. McCarron DA, Oparil S, Chait A, et al. Nutritional management of cardiovascular risk factors. Arch Intern Med 1997;157:169-77.
12. Snedecor GW, Cochran WG. Statistical methods. Ames, IA: The Iowa State University Press, 1973.
13. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
14. Zeger SL, Liang K. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
15. Lichtman SW, Pisarska K, Berman ER, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992;327:1893-8.
16. Heymsfield SB, Darby PC, Muhlheim LS, Gallagher D, Wolper C, Allison DB. The calorie: myth, measurement, and reality. Am J Clin Nutr 1995;62(suppl):1034S-41S.
17. Pi-Sunyer FX. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther 1996;18:1006-35.
18. Singh RB, Rastogi SS, Verma R, et al. Randomized controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ 1992;304:1015-9.
19. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. Prospective study of intentional weight loss and mortality in never-smoked overweight US women aged 40-64 years. Am J Epidemiol 1995;141:1128-41.
20. Chiang BN, Perlman LV, Epstein FH. Overweight and hypertension: a review. Circulation 1969;39:403-21.
21. The Trials of Hypertension Prevention Collaborative Research Group. The effect of nonpharmacologic interventions on blood pressure of persons with high normal levels; results of the Trials of Hypertension Prevention Phase I. JAMA 1992;267:1213-20.
22. Wing RR, Jeffery RW. Effect of modest weight loss on change in cardiovascular risk factors and maintenance. Int J Obes 1995;19:67-73.
23. Blackburn GL, Rosofsky W. Making the connection between weight loss, dieting, and health: the 10% solution. Weight Control Digest 1992;2:127-9.
24. Mathus-Vliegen EM, van de Voorde K, Kok AM, Res AM. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation on the effects of weight loss, cardiovascular risk factors, food intake, and eating behavior. J Intern Med 1992;232: 119-27.
25. O'Connor HT, Richman RM, Steinbeck KS, Caterson ID. Dexfenfluramine treatment of obesity: a double blind trial with post trial follow-up. Int J Obes 1995;19:181-9.
26. Abenheim L, Moride Y, Brenot F. et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-16.
27. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Obes Res 1998;6(suppl):51S-201S.